PREDICTING THE RATE OF BONE LOSS IN CROHN'S DISEASE USING BIOCHEMICAL MARKERS OF BONE TURNOVER
- Bone disease in patients with primary sclerosing cholangitis. Angulo, P.; Grandison, G. A.; Fong, D. G. // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 4, p163
IBD is commonly seen in patients with primary sclerosing cholangitis (PSC) and increases the risk of osteopenic bone disease in these individuals. Previous small investigations have identified a high rate of osteoporosis in PSC patients undergoing evaluation for liver transplantation. The...
- Prognosis of Crohn's disease. // British Medical Journal (Clinical Research Edition);5/2/1981, Vol. 282 Issue 6274, p1415
Presents a study on patients with Crohn's disease. Details of the medical approach in treating Crohn's disease; Incidence and causes of death in patients suffering from Crohn's disease; Association between Crohn's disease and carcinoma of the gastrointestinal tract.
- Follow-up treatment for osteoporosis after fracture. Hooven, Frederick; Gehlbach, Stephen H.; Pekow, Penelope; Bertone, Elizabeth; Benjamin, Evan // Osteoporosis International;Mar2005, Vol. 16 Issue 3, p296
Studies of the management of osteoporosis in older women who have had hip or wrist fractures have found underdiagnosis and undertreatment of the disease. Few such studies have been conducted in the United States, however, and most studies have been confined to a subset of the treatments...
- A New Look at Osteoporosis Outcomes: The Influence of Treatment, Compliance, Persistence, and Adherence. Badamgarav, Enkhe; Fitzpatrick, Lorraine A. // Mayo Clinic Proceedings;Aug2006, Vol. 81 Issue 8, p1009
The article presents a discussion on the influence of persistence, adherence, compliance and treatment for osteoporosis. It mentions that osteoporosis is a disease in which excess in bone resorption leads to decreased bone mass and an increase in its fragility. It emphasizes that for...
- Is a Calculated Total Hip BMD of Clinical Use? Selby, P. L.; McCloskey, E. V.; Robinson, J.; Smith, I. G.; Potts, B.; Beneton, M. N. C.; Kanis, J. A. // Osteoporosis International;May2000, Vol. 11 Issue 4, p368
: The diagnosis of osteoporosis is based on bone mass measurement. To avoid the errors associated with the measurement of spinal bone density the total hip has been accepted as the standard measurement site. This information is not available for many early measurements. We have assessed whether...
- Can Regional Enteritis Resolve Completely? Steigmann, Frederick // American Journal of Gastroenterology;Jun1975, Vol. 63 Issue 6, p464
Presents clinical information on Crohn's disease. Mortality risk of patients suffering from the disease; Difficulty in assessing the severity of the disease; Recommended treatment for the disease; Cases of patients with Crohn's disease.
- Increased Urinary N-Telopeptide Cross-linked Type 1 Collagen Predicts Bone Loss in Patients With Inflammatory Bowel Disease. Dresner-Pollak, Rivka; Karmeli, Fanny; Eliakim, Rami; Ackerman, Zvi; Rachmilewitz, Daniel // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p699
OBJECTIVE: Reduced bone mineral density (BMD) is common in patients with inflammatory bowel disease (IBD), but the factors associated with its longitudinal rate of change have not been established. We prospectively assessed the rate of change in BMD, and its association with biochemical markers...
- Pelvic--Femoral Osteomyelitis Complicating Crohn's Disease. Simpson Jr., Marcus B. // American Journal of Gastroenterology;May1984, Vol. 79 Issue 5, p379
Osteomyelitis of the pelvic bones arises in Crohn's disease when enteric fistulas from the ileocolonic region allow extention of the anaerobic intestinal flora to the psoas region of the right hemipelvis. Bone destruction is usually an unexpected finding during roentgenographic evaluation of...
- Treatment of Osteoporosis in Men. Orwoll, E. // Calcified Tissue International;Aug2004, Vol. 75 Issue 2, p114
Comments that osteoporosis in men is recognized as a clinical and public health problem. Lack of available data concerning treatment; Management of the patients by extrapolation from approaches used in women; Test of therapies for osteoporosis.